Literature DB >> 26309610

Protective effect of the ω-3 polyunsaturated fatty acids on the schistosomiasis liver fibrosis in mice.

Yuan Wu1, Yu Liang2, Yi Zhu3, Yongqiang Gao2, Hu Chen3, Yukuai Zhang2, Weiguo Yin2, Yingju Li2, Kegeng Wang2, Jianhua Xiao2.   

Abstract

This study aims to observe the effect of ω-3 polyunsaturated fatty acids on initiation and elimination of the schistosomiasis inflammatory response and liver fibrosis. The mice infected with the cercariae of Schistosoma japonicum (20 ± cercarie per mice) were separated randomly into several groups. After 60 days, liver tissue samples of all mice were sectioned. Hematoxylin-eosin (HE) staining, Masson staining, the enzyme-linked immunosorbent assay (ELISA), and flow cytometry (FCM) were performed. Through HE and Masson staining, the size of egg (ovum) granuloma and the collagen deposited in mice's livers in ω-3 PUFAs and praziquantel mixed groups were less than that of model group and praziquantel treated group. The serum level of IL-13 and TNF-α were lower than that of model group and praziquantel treated group. The indicators of liver fibrosis, such as HA and LN in the group treated with ω-3 PUFAs and praziquantel before the release of soluble eggs antigen (SEA) into blood, were lower than that of model group and praziquantel treated group, respectively. The combined treatment of ω-3 polyunsaturated fatty acids and praziquantel conducted before the release of soluble eggs antigens into the blood decreases liver ovum granulomatous inflammation and fibrosis degree in the schistosomiasis. The mechanism of the ω-3 polyunsaturated fatty acid may be related to the adjustment of the anti-inflammatory and immune responses.

Entities:  

Keywords:  Schistosoma japonicum; liver fibrosis; protective effect; ω-3 polyunsaturated fatty acids

Year:  2015        PMID: 26309610      PMCID: PMC4537995     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  8 in total

1.  Low serum docosahexaenoic acid is a significant risk factor for Alzheimer's dementia.

Authors:  D J Kyle; E Schaefer; G Patton; A Beiser
Journal:  Lipids       Date:  1999       Impact factor: 1.880

Review 2.  Mechanisms in anti-inflammation and resolution: the role of lipoxins and aspirin-triggered lipoxins.

Authors:  I M Fierro; C N Serhan
Journal:  Braz J Med Biol Res       Date:  2001-05       Impact factor: 2.590

3.  Effects of omega-3 fatty acids in rat allogenic small intestinal transplantation.

Authors:  K Ogita; S Suita; T Taguchi; T Yamanouchi; M Nakamura; S Taguchi; Y Nishimoto; T Uesugi
Journal:  Pediatr Surg Int       Date:  2003-04-04       Impact factor: 1.827

Review 4.  Reversibility of hepatic fibrosis: from the first report of collagenase in the liver to the possibility of gene therapy for recovery.

Authors:  I Okazaki; T Watanabe; S Hozawa; M Niioka; M Arai; K Maruyama
Journal:  Keio J Med       Date:  2001-06

5.  Antigen-driven murine CD4+ T lymphocyte proliferation and interleukin-2 production are diminished by dietary (n-3) polyunsaturated fatty acids.

Authors:  Lisa J Pompos; Kevin L Fritsche
Journal:  J Nutr       Date:  2002-11       Impact factor: 4.798

6.  Polyunsaturated fatty acids interfere with formation of the immunological synapse.

Authors:  René Geyeregger; Maximilian Zeyda; Gerhard J Zlabinger; Werner Waldhäusl; Thomas M Stulnig
Journal:  J Leukoc Biol       Date:  2005-02-09       Impact factor: 4.962

7.  Nutrition intervention: a strategy against systemic inflammatory syndrome.

Authors:  Helieh S Oz; Theresa S Chen; Manuela Neuman
Journal:  JPEN J Parenter Enteral Nutr       Date:  2009-04-14       Impact factor: 4.016

Review 8.  Models of liver fibrosis: exploring the dynamic nature of inflammation and repair in a solid organ.

Authors:  John P Iredale
Journal:  J Clin Invest       Date:  2007-03       Impact factor: 14.808

  8 in total
  1 in total

1.  A Polysaccharide from Amusium Pleuronectes Combined with Praziquantel Treatment Ameliorates Hepatic Fibrosis in Schistosoma Japonicum-Infected Mice.

Authors:  Xiaoniu Tang; Wei Hu; Yechao Lv; Wenqi Zhang; Tian Sun; Yuxin Jiang; Xiaodong Zhan; Shulin Zhou
Journal:  Med Sci Monit       Date:  2018-03-18
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.